Related Experiment Videos
Classification of death in antiarrhythmia trials
A E Epstein1, M D Carlson, R N Fogoros
1Department of Medicine, University of Alabama at Birmingham 35294-0006, USA.
Journal of the American College of Cardiology
|February 1, 1996
Summary
A new death classification scheme for antiarrhythmia trials was developed to better describe terminal events. This improved system aids in analyzing outcomes and comparing data across studies for arrhythmia research.
Area of Science:
- Cardiology
- Clinical Trials
- Medical Classification Systems
Background:
- Existing death classifications inadequately capture terminal event details in antiarrhythmia research.
- There is a need for a classification system that addresses unique aspects of arrhythmia investigations.
Purpose of the Study:
- To develop and implement a novel classification scheme for deaths occurring in antiarrhythmia treatment trials.
- To create a more comprehensive system for categorizing and analyzing mortality data in cardiac arrhythmia studies.
Main Methods:
- A new classification scheme was developed with categories including primary organ cause, temporal course, documentation, operative relation, and system relation.
- The scheme categorizes deaths based on cardiac (arrhythmic, nonarrhythmic, unknown), noncardiac, or unknown causes.
- It also considers the temporal course (sudden, nonsudden, unknown), documentation (witnessed, monitored), operative relation, and system relation of death.
Main Results:
- The classification scheme was successfully applied in a clinical trial involving an implantable cardioverter-defibrillator, analyzing 79 deaths among 1,250 patients.
- The scheme was also utilized in a device market approval application.
- Demonstrated the application of the new classification to data previously reported under older schemes.
Conclusions:
- The proposed classification scheme comprehensively describes and tabulates all significant aspects of terminal events.
- It integrates existing death categorizations with new ones relevant to arrhythmia investigations.
- The scheme provides sufficient data for robust comparison with findings from other studies.